EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages

Xiao Lei Chen, Kevin M Tharp, Marjaana Ojalill, Duygu Ozmadenci, Antonia Boyer, Terrance J Haanen, Christine Lawson, Hyojae J Lee, Marvin Xia, Elise Tahon, Yichi Zhang, Cray Minor und 15 weitere

Cell Reports · 2026-03 · 45 (3) · 117009

DOI: 10.1016/j.celrep.2026.117009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2026-03. Verfasst von Xiao Lei Chen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, Moores Cancer Center, Division of Gynecologic Oncology, University of California, Sa…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Chemokine CXCL13, Macrophages, Peritoneal, Fatty Acids, Omega-3. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsChemokine CXCL13Macrophages, PeritonealFatty Acids, Omega-3Focal Adhesion Kinase 1FemaleAnimalsHumansMiceCell Line, TumorMice, Inbred C57BLExosomesDoxorubicin

Stichwörter der Autor:innen

CP: cancerCXCL13FAKTIGITexosomesimmunotherapylipidomicsmacrophagesmicroenvironmentomega-3ovarian

Substanzen

Chemokine CXCL13Fatty Acids, Omega-3Focal Adhesion Kinase 1DoxorubicinCxcl13 protein, mouse

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Moores Cancer Center, Division of Gynecologic Oncology, University of California, San Diego, La Jolla, CA, USA.
  • Sanford Burnham Prebys Discovery Institute, Cancer Metabolism and Microenvironment Program, La Jolla, CA, USA.
  • Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pathology, Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Fox Chase Cancer Center, Cancer Signaling and Microenvironment Program, Philadelphia, PA, USA.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Maternal and Fetal Medicine, University of California, San Diego, La Jolla, CA, USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Hamner Institutes for Health Sciences
  • National Science Foundation
  • National Institutes of Health National Cancer Institute
  • V Foundation

Zitieren

APA

Chen, X. L., Tharp, K. M., Ojalill, M., Ozmadenci, D., Boyer, A., Haanen, T. J., Lawson, C., Lee, H. J., Xia, M., Tahon, E., Zhang, Y., Minor, C., Khan, S. U., Anderson, C. C., Nemkov, T., Rose, M., Estrada, M. V., Molinolo, A. A., Warren, E., …, & Schlaepfer, D. D. (2026). FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages. Cell Reports, 45(3), 117009. https://doi.org/10.1016/j.celrep.2026.117009

Vancouver

Chen XL, Tharp KM, Ojalill M, Ozmadenci D, Boyer A, Haanen TJ, et al. FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages. Cell Reports. 2026;45(3):117009. doi:10.1016/j.celrep.2026.117009

BibTeX
@article{Chen2026,
  author = {Chen, Xiao Lei and Tharp, Kevin M and Ojalill, Marjaana and Ozmadenci, Duygu and Boyer, Antonia and Haanen, Terrance J and Lawson, Christine and Lee, Hyojae J and Xia, Marvin and Tahon, Elise and Zhang, Yichi and Minor, Cray and Khan, Safir Ullah and Anderson, Colin C and Nemkov, Travis and Rose, Michael and Estrada, Monica V and Molinolo, Alfredo A and Warren, Elias and Penalosa, Patrick and Eskander, Ramez N and McHale, Michael T and Wang, Shizhen E and Connolly, Denise C and Fisch, Kathleen M and Stupack, Dwayne G and Schlaepfer, David D},
  title = {FAK inhibition in ovarian cancer releases omega-3 fatty acids to program CXCL13-producing anti-tumor resident peritoneal macrophages},
  journal = {Cell Reports},
  year = {2026},
  volume = {45},
  number = {3},
  pages = {117009},
  doi = {10.1016/j.celrep.2026.117009}
}
Kostenlos starten →